Abstract

Adjuvant diagnostic and therapeutic procedures reduce the risk of recurrence and progression in high-risk non-muscle-invasive bladder cancer (NMIBC) (Poletajew et al. in Neoplasma 65(1):147–152, 2018). However indications and oncological outcomes are varied. Poletajew et al. (Neoplasma 65(1):147–152, 2018), reviewed therapeutic decisions in primary high-risk NMIBC and adherence to clinical guidelines in this field. This chapter deals with prognostic factors in endoscopic resection in NMIBC.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call